We are live on !
Find out more
LDFR
Lehman & Derafelo Financial Resources Portfolio holdings
AUM
$337M
Turnover
53.08%
1-Year Est. Return
8.16%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
-8.16%
3 Year Est. Return
+37.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$19.9M
(+6.3%)
Cap. Flow
+$2.41M
Cap. Flow % of AUM
Cap. Flow %
0.72%
Top 10 Holdings %
Top 10 Hldgs %
68.44%
Holding
211
New
11
Increased
32
Reduced
42
Closed
101
Avg Time Held
Equity + Options
3
years
Top 10 Avg Time Held
Equity + Options
3
years
Top 20 Avg Time Held
Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.65M |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
+$2.16M |
| 3 |
Leatherback Long/Short Alternative Yield ETF
LBAY
|
+$1.31M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$898K |
| 5 |
Mastercard
MA
|
+$830K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.53M |
| 2 |
Fidelity Dividend ETF for Rising Rates
FDRR
|
+$1.45M |
| 3 |
NextEra Energy
NEE
|
+$649K |
| 4 |
Sarepta Therapeutics
SRPT
|
+$559K |
| 5 |
Tesla
TSLA
|
+$413K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Utilities | 36.98% |
| 2 | Miscellaneous | 27.73% |
| 3 | Financials | 10.55% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
NextEra Energy
NEE
$164B
| $97M | 28.78% |
1,160,606
-8,030
| -0.7% | -$649K |
2018 Q4
16 quarters
|
|
|
2
Leatherback Long/Short Alternative Yield ETF
LBAY
$17.5M
| $30.1M | 8.94% |
1,025,944
+46,502
| +5% | +$1.31M |
2020 Q4
8 quarters
|
|
3
XPLR Infrastructure LP
XIFR
$928M
| $25.2M | 7.47% |
359,102
-1,567
| -0.4% | -$117K |
2018 Q4
16 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.14T
| $19.6M | 5.83% |
63,582
+2,672
| +4% | +$794K |
2018 Q4
16 quarters
|
|
5
Amazon
AMZN
$2.76T
| $11.1M | 3.28% |
131,737
+936
| +0.7% | +$92.5K |
2018 Q4
16 quarters
|
|
6
Pfizer
PFE
$169B
| $10.9M | 3.22% |
211,824
-1,115
| -0.5% | -$53.5K |
2018 Q4
16 quarters
|
|
|
7
Fidelity Dividend ETF for Rising Rates
FDRR
$765M
| $10.5M | 3.11% |
263,357
-37,044
| -12% | -$1.45M |
2018 Q4
16 quarters
|
|
8
CVS Health
CVS
$118B
| $10.1M | 2.99% |
108,233
-1,609
| -1% | -$155K |
2019 Q3
13 quarters
|
|
9
Bank of America
BAC
$358B
| $9.11M | 2.7% |
275,085
+1,790
| +0.7% | +$61.7K |
2018 Q4
16 quarters
|
|
|
10
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $7.15M | 2.12% |
18,697
+12,111
| +184% | +$4.65M |
2018 Q4
16 quarters
|
|
11
iShares US Medical Devices ETF
IHI
$3.71B
| $6.27M | 1.86% |
119,317
-2,067
| -2% | -$105K |
2020 Q2
10 quarters
|
|
|
MMP
12
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.48M | 1.62% |
109,054
-2,415
| -2% | -$123K |
2018 Q4
16 quarters
|
|
13
Apple
AAPL
$5.01T
| $5.26M | 1.56% |
40,450
+26
| +0.1% | +$3.72K |
2018 Q4
16 quarters
|
|
|
14
iShares Core S&P 500 ETF
IVV
$884B
| $4.74M | 1.41% |
12,336
-11,745
| -49% | -$4.53M |
2018 Q4
16 quarters
|
|
15
Merck
MRK
$361B
| $4.68M | 1.39% |
42,190
-509
| -1% | -$52K |
2018 Q4
16 quarters
|
|
16
L3Harris
LHX
$45.6B
| $2.96M | 0.88% |
14,203
| – | – |
2019 Q3
13 quarters
|
|
17
State Street Communication Services Select Sector SPDR ETF
XLC
$23.3B
| $2.61M | 0.78% |
54,450
+499
| +0.9% | +$24.4K |
2021 Q1
7 quarters
|
|
18
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.99B
| $2.59M | 0.77% |
51,325
-2,500
| -5% | -$126K |
2020 Q1
11 quarters
|
|
19
Johnson & Johnson
JNJ
$612B
| $2.58M | 0.76% |
14,592
-87
| -0.6% | -$15K |
2018 Q4
16 quarters
|
|
20
Enterprise Products Partners
EPD
$79.5B
| $2.5M | 0.74% |
103,770
-5,507
| -5% | -$136K |
2018 Q4
16 quarters
|
|
21
Microsoft
MSFT
$3.95T
| $2.49M | 0.74% |
10,404
+374
| +4% | +$89.8K |
2018 Q4
16 quarters
|
|
22
Golub Capital BDC
GBDC
$3.12B
| $2.49M | 0.74% |
189,042
-8,542
| -4% | -$113K |
2020 Q3
9 quarters
|
|
23
Gilead Sciences
GILD
$194B
| $2.3M | 0.68% |
26,777
-800
| -3% | -$63.4K |
2018 Q4
16 quarters
|
|
|
24
iShares Core Dividend Growth ETF
DGRO
$43.9B
| $2.2M | 0.65% |
+44,066
| New | +$2.16M |
2022 Q4
0 quarters
|
|
25
ExxonMobil
XOM
$736B
| $2.11M | 0.62% |
19,098
-1,396
| -7% | -$150K |
2018 Q4
16 quarters
|
|
Similar funds
MPAM
MAG
EP
A
RIM
AAM
YWP
BC
Lehman & Derafelo Financial Resources's Q4 2022 Portfolio in Review
As of Q4 2022, Lehman & Derafelo Financial Resources held 211 positions worth $337M, up 6.3% from $317M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Lehman & Derafelo Financial Resources's Q4 2022 filing shows 11 new, 32 increased, 42 reduced and 101 closed positions. Its largest new stake was iShares Core Dividend Growth ETF: 44,066 shares worth $2.2M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.53M.
By sector, the portfolio is most concentrated in Utilities at 37% of assets, down from 38% a quarter earlier, followed by Miscellaneous and Financials.
- Lehman & Derafelo Financial Resources's largest Q4 2022 buy was iShares Core Dividend Growth ETF: 44,066 shares worth $2.2M.
- Lehman & Derafelo Financial Resources added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $4.65M increase.
- Lehman & Derafelo Financial Resources's biggest Q4 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.53M.
- Lehman & Derafelo Financial Resources fully exited Sarepta Therapeutics in Q4 2022, selling an estimated $559K.
- Lehman & Derafelo Financial Resources's ten largest holdings make up 68% of its $337M portfolio in Q4 2022.
- Lehman & Derafelo Financial Resources opened 11 new positions and closed 101 in Q4 2022.
- Lehman & Derafelo Financial Resources's portfolio value rose 6.3% quarter-over-quarter to $337M.
Based on Lehman & Derafelo Financial Resources's 13F filing for Q4 2022, filed 20 Jan 2023.